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Abstract
Background: Biofilm formation and deep infection of endoprostheses is a recurrent complication
in implant surgery. Post-operative infections may be overcome by adjusting antimicrobial
properties of the implant surface prior to implantation. In this work we described the development
of an antimicrobial titanium/silver hard coating via the physical vapor deposition (PVD) process.
Methods: Coatings with a thickness of approximately 2 µm were deposited on titanium surfaces
by simultaneous vaporisation of both metals in an inert argon atmosphere with a silver content of
approximately 0.7 – 9% as indicated by energy dispersive X-ray analysis. On these surfaces
microorganisms and eukaryotic culture cells were grown.
Results: The coatings released sufficient silver ions (0.5–2.3 ppb) when immersed in PBS and
showed significant antimicrobial potency against Staphylococcus epidermis and Klebsiella pneumoniae
strains. At the same time, no cytotoxic effects of the coatings on osteoblast and epithelial cells were
found.
Conclusion: Due to similar mechanical performance when compared to pure titanium, the TiAg
coatings should be suitable to provide antimicrobial activity on load-bearing implant surfaces.
Background
Deep infection of endoprostheses remains a serious com-
plication in orthopedic surgery since the systemic treat-
ment of infected bone with antibiotics is often impossible
due to the poor accessibility of the infection site by
applied antibiotics [1]. The primary infection rate in total
hip arthroplasty was found to be approximately 1–3% [2]
and the rate of re-infection after revision of infected hip
prostheses is up to 14% [3]. The reason for a post-opera-
tive infection is mainly due to a contamination of the
implant surface during implantation with the formation
of a resistant biofilm as well as a haematogenic bacterial
spreading (e.g. after tooth extraction) [4]. Chronically
infected endoprostheses have to be explanted, common
therapies involve the use of temporary antibiotic loaded
PMMA spacer-implants [5,6] or antibiotic loaded cements
[7]. Although these therapies show good results and reim-
plantation is successful in most cases, a risk of creating
bacterial resistance due to low releasing doses persists [5-
7].
Post-operative infections may be overcome by adjusting
antimicrobial properties of the implant surface prior to
implantation. Techniques described in literature are direct
impregnation with antibiotics [8] prior to implantation or
using antibiotic or silver doped polymer coatings. Silver-
based antimicrobials are of interest due to the non-toxic-
ity of the active Ag+ to human cells [9,10] and the antimi-
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crobial activity of silver ions has been well established.
Silver ions are significant antimicrobials with only few
bacteria being intrinsically resistant to this metal through
plasmid derived resistance mechanisms [11-14]. Incorpo-
ration of silver ions into polymeric materials has been
widely used for several years; especially urinary and cen-
tral venous catheters are provided with silver coatings to
reduce infections. Medical devices like heart valves or dial-
ysis units also benefit from the use of silver doted surfaces
[15-18].
However, most of the techniques used do not fulfil the
mechanical criteria for load-bearing implants because
especially the implantation into the bone results in high
(abrasive) shear forces between bone and the implant sur-
face. The aim of this study was the development of a
metallic hard coating based on titanium/silver alloys
which provides antimicrobial properties due to the silver
content as well as a high biocompatibility in contact with
bone. Titanium samples were coated with the silver-tita-
nium-alloys containing up to 9% silver by using the phys-
ical vapour deposition (PVD) process and tested for
hardness, biocompatibility and bactericide action. The
PVD process is known to result in good adhesiveness and
wear resistance of metallic or ceramic coatings and is
widely used in technical and medical applications [19].
The coatings are aimed to provide antimicrobial proper-
ties due to the release of silver ions in an aqueous environ-
ment while maintaining the biocompatibility and
hardness of titanium against hard and soft tissue for an
application on load-bearing implants, e.g. in hip or knee
arthroplasty.
Materials and methods
Sample preparation
Cylindrical titanium specimens (16 mm diameter × 1 mm
height) were cut from technical grade titanium sheet
(ASTM-Nr. B 265–95, Grade 2, Zapp, Düsseldorf, Ger-
many). The specimens were cleaned ultrasonically in pure
water followed by alkaline Extran®-solution and an addi-
tional incubation in pure water for 10 min at 40°C each.
Drying and storage of the specimens occurred under clean
room conditions until positioning in the recipient. The
titanium/silver coatings were manufactured by using a
PVD-system type PLS 570 (Pfeiffer Vacuum, Germany).
Vaporisation of the metal components occurred by means
of an arc (titanium) and a magnetron sputter (silver) from
metallic targets. Mixed coatings were produced by simul-
taneous vaporisation of both metals while the titanium
substrate was rotated with a frequency of 0.5 Hz. After
evaporation the specimens were physically cleaned in an
argon plasma (p = 6.4·10-3 mbar; 200 W) for 30 min and
through this heated to the start temperature of approxi-
mately 200°C. Processing parameters for all coatings were
an argon atmosphere of 7.5·10-3 mbar, a substrate voltage
US of -300 VDC, a coating time of 30 min and a constant
arc current (for vaporising the titanium component) of
80A while the magnetron powder (silver component) was
varied between 112 – 900 W to modify the ratio between
the two vaporized metal components.
Surface characterisation
The surface roughness was measured with a profilometer
Surftest 211 (Mitutoyo, Japan); 3 measurements were car-
ried out at various positions on the surface, the average
and the standard deviation were calculated. The hardness
of the coatings was determined by measuring the Vicker's
hardness HV10 (Zwick, Ulm, Germany). SEM-analyses
were performed with a DSM 940 (Zeiss, Oberkochen, Ger-
many). EDX-analyses of the surfaces were recorded with a
QX2000 system (Link, England) at a working distance of
25 mm and an acceleration voltage of 10 kV. The EDX
spectra were quantified using the internal ZAF software.
The silver ion release of the coatings was measured with
inductively coupled plasma mass spectroscopy (ICP-MS).
Samples (n = 3 per condition) were immersed in 10 ml
phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM
KCl, 7.0 mM Na2HPO4 × 2 H2O, 1.5 mM KH2PO4) at
37°C. The buffer solution was replaced and analysed after
1 d, 2 d, 4 d, 10 d and 14 d with a Varian ICP-MS against
standard solutions (Merck, Darmstadt, Germany).
Antimicrobial properties
For analysing the antimicrobial properties of the tita-
nium/silver coatings samples were exposed to gram posi-
tive  Staphylococcus epidermidis, strain RP62A (ATCC
35984) or gram negative Klebsiella pneumoniae, strain
3091 [20]. The microorganisms were grown in LB broth
(1% w/v Tryptone, 0.5% w/v Yeast extract, 0.5% w/v
NaCl) at 37°C. Titanium samples were placed into 24
well plates (Nunc, Wiesbaden, Germany), covered with 1
ml bacteria suspension in logarithmic growth phase and
incubated by gentle rotation for 24 hours at 37°C.
Adhered organisms were dehydrated in 50%, 80%, and
two times 90% Ethanol for 5 min each. The specimens
were air dried and incubated for 15 min with 1 ml SYBR®-
green (Molecular probes™, Invitrogen Life Technologies,
Karlsruhe, Germany) diluted 1:100 000 in TBS (10 mM
Tris-HCl, pH 7.4; 140 mM NaCl). Adhered microorgan-
isms were quantified by evaluating the fluorescence in a
Spectrafluor plus photometer (Tecan, Crailsheim, Ger-
many) with the appropriate calculation software (X-Fluor,
Tecan, Germany). Three samples were analyzed per sur-
face modification and average and standard deviation
were calculated. Statistical analysis was performed by
using the Anova t-test of Microsoft Excel.
Cell culture
Epithelial cells 16HBE were cultured in Dulbecco's Modi-
fied Eagle's Medium (DMEM, Invitrogen Life Technolo-BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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gies, Karlsruhe, Germany), human osteoblast cell line
hFOB1.19 [21] was cultured in DMEM/NUT MIX F-12
(HAM, Invitrogen Life Technologies). The culture media
were supplemented with 10% fetal calf serum, 1% penicil-
lin and streptomycin, respectively (Invitrogen Life Tech-
nologies) and the cells incubated in a humidified 5% CO2
incubator at 37°C. For biocompatibility testing the sam-
ples were placed in triplicate into a 24-well plate (Nunc,
Wiesbaden, Germany), cells were seeded onto silver con-
taining titanium surfaces or on polystyrene, respectively,
with an initial density of 50 000 cells per well.
Biocompatibility testing
For testing the biocompatibility of titanium/silver sur-
faces cell proliferation, cell viability and total protein con-
tent of the samples were determined after 3, 5, 7, and 10
days of culture. Cell proliferation was determined by elec-
tronic cell counting using a CASY 1 TTC cell analyzer
(Schärfe System, Reutlingen, Germany). For this purpose,
cells were detached by incubation with Accutase (PAA,
Cölbe, Germany) after two washes in PBS. The reaction
was stopped by adding equal amounts of DMEM. After
diluting the cell suspension 1:100 in 10 ml Isoton III
(Beckmann Coulter, Krefeld) cells were counted and the
number was calculated automatically by the Casy-stat
software (Schärfe System). Cell viability and proliferation
was analysed by using cell proliferation reagent WST 1
(Roche Diagnostics, Mannheim, Germany). After incubat-
ing the cells for 30 min with the WST reagent 1:10 in
DMEM at 37°C, the adsorption of the supernatant was
quantified in a Tecan spectra fluor plus photometer
(Tecan, Crailsheim, Germany). Total protein content of
the cells was quantified applying the DC Protein Assay
(BioRad, Munich, Germany) according to manufacturers'
instructions. The adsorption was measured in a Tecan
spectra fluor plus photometer. For each analysis the sam-
ples were examined in triplicate and the average and
standard deviation was calculated. For statistical analysis
the Anova t-test of Excel was performed.
Results
PVD coating of titanium resulted in the deposition of thin
metallic films with a thickness of approximately 2 µm as
determined from cross-section images. SEMs of the coat-
ings are displayed in Figure 1. Independent of silver con-
tent, the surfaces showed similar surface structures. EDX
spectra of the coatings (Figure 2) showed the presence of
small amounts of silver within the surface. Quantification
of the spectra using the ZAF software indicated a silver
content between 0.7% and 9%. The appropriate composi-
tion was found to be homogeneous all over the surface as
screened by EDX analysis (with a lateral resolution of
approximately 100 µm2) at different surface positions.
The coating procedure increased the medium surface
roughness Ry only marginally (Table 1) from 2.8 µm to
4.5 µm (9% silver content) and the coatings provided
Table 1: Surface roughness and Vickers hardness HV10 of TiAg-
coated titanium surfaces (n = 3).
Ag content [%] Ry [µm] HV10
titanium substrate 2.80 +/- 0.21 193 +/- 1.67
0.7 3.79 +/- 0.62 215 +/- 4.18
3 4.16 +/- 0.23 189 +/- 3.21
4 4.13 +/- 0.27 205 +/- 7.60
9 4.56 +/- 0.80 214 +/- 3.63
100 2.98 +/- 0.12 188 +/- 3.96
EMOF Figure 1
EMOF. Scanning electron micrographs of a titanium surface 
(A) and titanium surfaces coated with TiAg alloys. B 0% Ag, C 
0.7% Ag, D 3% Ag, E 4% Ag and F 9% Ag. (bar = 10 µm for A 
– F). The thickness of the coating is about 2 µm as deter-
mined by electron microscopy (G, bar = 5 µm).BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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Vickers hardness in the same range as unmodified tita-
nium. When immersed in PBS, the surfaces continuously
released silver ions (Figure 3); concentrations determined
by ICP-MS analysis were in the range between 0.5 to 2.3
ppb at 0.7 – 9% silver content compared to 60–100 ppb
for a pure silver reference surface.
Antimicrobial properties
Figure 4 shows the reaction of Staphylococcus epidermis and
Klebsiella pneumoniae strains to silver doted surfaces com-
pared to commercial pure titanium grade 2 as control.
Bacterial adherence to control surfaces was set to 100%
and the contamination on the argentiferous surfaces was
calculated accordingly. Klebsiella pneumoniae showed a sig-
nificant reduction of adhesion (p < 0.05) on 0.7% up to
4% silver surfaces ranging from 32% to 64%. The decrease
of microorganism adhesion on 9% silver was not signifi-
cant for Klebsiella. The dwindling of Staphylococcus epider-
midis adhesion was significant (p < 0.01) on all surfaces
tested ranging from 52% on 0.7% silver to 43% on 4% sil-
ver.
Biocompatibility properties
Biocompatibility tests were performed using epithelial
and osteoblast cell lines, both predestinated for getting in
contact with implant surfaces. Especially osteoblast cells
are expected to grow directly on the implant surface in
contact with bone. Epithelial cell activity showed a signif-
icant reduction on 3% silver surfaces after 5 and 7 days
and on 4% silver surfaces after 5 and 10 days, on 9% silver
the cell activity was increased significantly on day 5 and
10 (p < 0.01) (fig. 5A). Determination of total cell protein
on the various surfaces yielded a significant increase of
protein on 3% and 9% silver containing surfaces after 5
and 10 days as well as on 4% silver surfaces on day 7 and
10 and on 9% silver after 7 days (p < 0.01) (fig. 5B). Figure
6 summarizes the results for the osteoblast cell line. Cells
showed comparable or significantly higher activity on
most of the surfaces tested (3% silver day 3, 4% silver day
3, 9% silver day 3; p < 0.01). Cell activity is significantly
decreased (p < 0.01) on 3% silver after 10 days and on 9%
silver after 5 and 9 days (fig. 6A). Total protein content of
osteoblasts cultivated on argentiferous titanium was
increased on 1% silver on day 5, on 4% silver on day 3
and 5, and on 18% silver on day 3 (p < 0.01). On 1% sil-
ver (day 7 and 9), 4% (day 7), and 18% (day 7 and 9),
ICP Figure 3
ICP. Ag+ release from TiAg coatings over 6 days (n = 3); the 
immersion liquid (PBS) was replaced daily.
EDX Figure 2
EDX. EDX-analysis of TiAg-PVD coatings on titanium; A) 
3%, B) 4%, C) 9% and D) 100% (silver contents were were 
obtained by quantifying the EDX spectra using the ZAF soft-
ware).BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
Page 5 of 10
(page number not for citation purposes)
Bact Figure 4
Bact. Adhesion of bacterial strains on argentiferous surfaces. A) Klebsiella pneumoniae adhesion is significantly (p < 0.05%) 
reduced on surfaces containing 3% silver. B) Staphylococcus epidermidis adhesion is significantly (p < 0.01%) reduced on all of 
the silver containing surfaces.BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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Epi Figure 5
Epi. Cytotoxicity tests with epithelial cells. A) Epithelial cell activity is not significantly (p < 0.01%) reduced on silver containing 
surfaces. B) Epithelial cell protein content is not significantly (p < 0.01%) reduced on silver containing surfaces.BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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Osteo Figure 6
Osteo. Cytotoxicity tests with osteoblast cells. A) Osteoblast cell activity is not significantly (p < 0.01%) reduced on silver 
containing surfaces. B) Osteoblast protein content is not significantly (p < 0.01%) reduced on silver containing surfaces.BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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total protein content was decreased (p < 0.01) when com-
pared to pure titanium surfaces (fig. 6B). According to
DIN EN ISO 10993 and to ISO 7405:1997, the silver
doted titanium surfaces showed no cytotoxicity on epithe-
lial and osteoblast cells.
Discussion
Biofilm formation is a recurrent complication in implant
surgery. Implanted devices are ideal substrates for biofilm
forming microorganisms, which colonise short term
implants such as catheters as well as long term prostheses
like artificial hip or knee joints [22]. The biofilm forma-
tion proceeds successively. In a first step, microorganisms
associate transiently to the surface, followed by a robust
adhesion. After aggregation and formation of microcolo-
nies the biofilm grows and matures. During this process
proteins, glycoproteins and, carbohydrates are incorpo-
rated and microorganisms cease division [23,24]. As anti-
biotics perform their bactericidal features by impairing
cell division processes, non-dividing microorganisms liv-
ing in biofilms are no longer susceptible to antibiotics and
exhibit a transient resistance to these substances. On the
other hand the compact structure of biofilms constitutes a
diffusion barrier for antibiotics [25-27].
Since it has been shown that microorganisms and host
cells compete for the substrate in a process called "race for
the surface" [28], device surfaces should prevent microor-
ganisms from adhering in order to promote host tissue
interaction with the implant. Antimicrobial properties of
implant surfaces can be obtained by either impregnation
of the surface with antibiotics [29] or modification of the
surface or the bulk material with silver which is slowly
released during the application [30,31]. For this reason we
hypothesised that coating of titanium with a silver/tita-
nium alloy will result in bacteria repellent properties
while maintaining the biocompatibility to eukaryotic
cells. The low resistance rate in bacteria toward silver ions
is advantageous compared to antibiotics modified sur-
faces. Although plasmid derived resistance in microorgan-
isms living in halide containing environments has been
described, up to now only few cases of silver resistant bac-
teria were found in hospital [14]. The antimicrobial activ-
ity of silver is dependent on the silver cation Ag+, which
strongly binds to electron donor groups in biological mol-
ecules containing sulphur, oxygen or nitrogen. The bio-
logical performance of silver ions is dose dependent. Low
concentrations <35 ppb are mainly bactericide, while
higher doses can be a toxic to human cells, ranging from
low or high local toxicity to systemic effects like argyria in
high doses (>4–6 g total silver content in the body) [40].
Hence the silver-based antimicrobial materials have to
release Ag+ ions to create a pathogenic environment in
order to be effective. The oxidation of metallic silver to the
active species (Ag+) is mediated through an interaction of
the silver with the aqueous environment. Silver coatings
are commonly applied on polymer-implants and recently,
the silver coating of foreign materials such as heart valves,
central venous catheters and urinary catheters has proved
to reduce the infection rate of medical devices [15-18].
Currently, no titanium based material utilizing the anti-
microbial qualities of silver ions is available for load bear-
ing implants, like artificial joint replacements.
In this work, we developed a coating method for metallic
surfaces with titanium/silver modifications by using the
physical vapor deposition (PVD) technique. During this
procedure, a defined mixture of silver and titanium is
deposited onto the surface by simultaneous vaporization
of metallic targets in vacuum. The resulting samples dis-
played surface roughness and hardness comparable to
pure titanium, a silver content of approximately 0.7 – 9%
within the coatings was confirmed by EDX analysis.
According to the TiAg phase diagram [32], it is likely that
at low silver concentrations < 3% a solid solution of Ag in
α Ti was formed during coating deposition, while at
higher concentrations a binary phase mixture of α Ti and
Ti2Ag should be present. A constant and prolonged release
of silver ions at concentration levels of at least 0.1 ppb
[33] is the minimum requirement for a bacteria repellent
surface. In this study Ag+ ions were formed by oxidation of
the surface in contact with an aqueous electrolyte. Mecha-
nistically, the silver/titanium alloy forms a galvanic ele-
ment in which silver is the anode and titanium the
cathode and therefore titanium is oxidised as less noble
element. However, the titanium is rapidly passivated dur-
ing this process with a thin TiO2 coating which is non-
conductive and inhibits further electron transfer into the
electrolyte. From this time point on, the silver is simply
chemically oxidised and silver ions are released into the
electrolyte. Even at the lowest silver content (0.7%) Ag+
concentrations released into the medium are more than 5
fold higher than the concentrations necessary for antimi-
crobial activity as determined by ICP mass spectrometry.
Since Ag+ is able to form low soluble salts with chloride or
sulfide ions, this might reduce the Ag+ concentration in
the electrolyte and hence reduce antimicrobial activity.
Assuming a Cl- concentration of approximately 160 mmol
in PBS or serum and a solubility product of AgCl of 10-10
mol2/l2, the concentration of free silver ions in serum is
estimated to be 0.27 ppb under equilibrium conditions,
which is still above the minimum concentration necessary
for bacterial inhibition. Since the surfaces are intended to
exhibit microorganism repellent properties only locally in
order to prevent biofilm formation on the implant, bind-
ing of Ag+ to serum proteins should be irrelevant.
To examine the antimicrobial properties of the argentifer-
ous surfaces, two bacterial strains, frequently involved in
nosocomial infections, were chosen. Staphylococcus epider-BioMedical Engineering OnLine 2006, 5:22 http://www.biomedical-engineering-online.com/content/5/1/22
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midis is a commensalistic skin microorganism which is
not pathogenic in healthy individuals, but can cause seri-
ous wound and implant infections after implant surgery
[34-36].  Klebsiella pneumoniae is also known to be
involved in implant associated infections [18,37,38]. On
3% silver the colonization of the surfaces was reduced by
64% for Klebsiella pneumoniae surfaces. The adhesion of
Staphylococcus epidermidis was reduced by about 50% on
all surface concentrations. Surprisingly, no obvious
dependency of bacterial contamination decrease on the
released silver ion concentration was found. This could be
due to the reaction of the silver ions with halogenide ions
in the serum resulting in the formation of unreactive AgCl
precipitate, which is thought to reduce the concentration
of free silver ions for all surfaces to approximately 0.27
ppb as calculated in the previous paragraph. The bacterial
strains used in our test system showed different sensitivi-
ties to silver ions. Mechanistically, the mode of action at
low silver concentrations is an interference of Ag+ with the
murein of the bacterial cell wall [39]. Differences in sensi-
tivity are therefore very likely dependent on the type of
bacteria since Staphylococcus epidermidis is a gram positive
organism whereas Klebsiella pneumoniae is gram negative.
At the same time the surfaces showed no cytotoxicity for
eukaryotic cells like epithelial or osteoblast cells. The cyto-
toxicity for eukaryotic cells was tested according to DIN
EN ISO 10993-5 by measuring cell activity and total pro-
tein content of the cells. Reference surfaces were polysty-
rene from the tissue culture dish. Epithelial cells showed
comparable activity on all surfaces tested. Only the sam-
ple grown on 4% silver had a drastically reduced activity
after five days. Since the cells grew properly on day 9, this
phenomenon may be due to an early detachment of cells.
The assay for total protein content showed reasonable
results and the protein level was not reduced on any sur-
face. Cell activity tests for osteoblasts yielded equal results
on polystyrene, 3%, and 5% silver surfaces, respectively.
Only on 9% silver surfaces the cell activity was reduced on
day 5. The total protein content of osteoblasts grown on
argentiferous surfaces is comparable among the different
samples, showing no cytotoxic effects of the surfaces on
eukaryotic cells. This is in agreement with a recent in vivo
study, where silver coated titanium implants (Mutars®
prostheses) have been placed into rabbits. Compared to
titanium prostheses, the silver coated prostheses showed
significantly lower infection rates with Stapylococcus
aureus, without showing toxic side effects on the sur-
rounding tissues [40]. Similar results were obtained in
other studies with silver coated polymer surfaces and
stainless steel pins also showing no cytotoxicity [31,41].
Conclusion
In this work we managed to produce a hard coating suita-
ble to provide metal surfaces with antibacterial properties.
Titanium/silver hard coatings were established via physi-
cal vapor deposition with significant antimicrobial
potency and the absence of cytotoxical effects on osteob-
lasts and epithelial cells. In future this surface modifica-
tion may be applied to load bearing implants. Further
work should be focused on an increase of the hardness of
the coatings, e.g. by sputtering in reactive atmosphere
(oxygen, nitrogen) which would lead to TiAg(O,N) coat-
ings similar to TiZr or TiNb coatings as described previ-
ously by our group [19]. A further simplification of the
coating process may be achieved by using single target
made from a titanium/silver alloy.
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